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AN ANALOGYs INTERFERON AND ENDOGENOUS PYROGEN 
Introduction 
For a number of years it has been observed that host resistance 
to the effects of viral infections could be enhanced by gram negative 
42 
bacteria and their products9 particularly endotoxins* (Sidotoxins 
are high molecular weight lipopolysaccharides derived from virtually 
all gram negative bacteria* Their exact structure and the factors re- 
sponsible for their extraordinary toxicity remain unidentified.^) 
» 55 
Specifically, Groupe in 1956 demonstrated that xerosin, an endotoxin*® 
like material from Achromobacter xerosis, could suppress the neurotoxic 
effect of influenza virus in mice when given intracerebrally before, 
but not after, inoculation of virus by the same route. Gledhill re¬ 
ported that serum of mice treated with endotoxin present in growth 
filtrates of Salmonella typhimurium when inoculated into suckling 
49 
mice increased resistance to ectromelia virus infection* He also 
demonstrated similar effects with saccharated iron oxide and concluded 
that stimulation of the reticuloendothelial system was the mechanism 
48 
involved* Also, Wagner et® al• were able to increase resistance of 
mice to eastern equine encephalitis and encephal©myocarditis viruses 
155 
by administration of endotoxin® 
More recently, there have appeared in the literature suggestions 
that the *’hon»specificM enhanced resistance to virus infections caused 
by bacterial endotoxins might be due to the production of the low 




and Youngner and Ho reported that bacterial endotoxins do, 
in fact, induce the release of an interferon-like material in vivo 
in chickens, mice and rabbits# 
It has been known for some time that one of the most sensitive 
indices of endotoxin activity is its pyrogenic effect in laboratory 
animals,®^ As little as 0*0001|jg per kilogram is capable of producing 
90 
a detectable pyrogenic response in the rabbit. The mechanism by which 
endotoxins cause fever has been attributed to the release into the 
9 1 25 
circulation of an endogenous pyrogen, * ' which can be differentiated 
from endotoxin and will cause a fever when injected into a recipient 
animal« 
Thus, because of these observations, viz, that endotoxins induce 
release of both endogenous pyrogen and interferon, it was the proposal 
of this thesis to investigate a possible relationship between these 
two entities using a single inducer-host system. 
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Interferon? A Review 
Although the phenomenon of viral interference had been, upto 
that time., demonstrated by several investigatorsf4*^91^ nrior 
to 1957, no one Identified an active interfering principle distinct 
from virus material itself or from part of the host’s immunologic 
response# It remained for Isaacs and Lindenmarm to achieve some 
preliminary characterization of such a substance? they called it 
wthe interferon.w^Using heat-inactivated influenza virus and 
fragments of chick chorio-allantoic membrane, they found a soluble 
factor was released that induced interference in fresh pieces of 
chorio-allantoic membrane. Until this time, all Interference had 
been considered to be a direct effect of whole interfering virus or 
of virus components®''’'' The interferon of Isaacs and Lindenmarm was 
stable in the cold but inactivated at 60°C for 1 hour. It was not 
dialyzabie nor was it sedimented by 100,000 g for ■§- hour. Interferon 
produced in response to influenza A was active against homologous 
virus, Sendai, Newcastle Disease and vaccinia viruses. It was not 
neutralized by specific anti-serum and did not agglutinate red blood 
cells. Their astute initial observations have lead to a whole new 
field of research and a voluminous literature concerning this sub¬ 
stance that, it is hoped, might curtail a wide range of virus infections. 
Definition? 
There has been considerable difficulty in defining exactly what 
interferon is? one must resort to listing a number of characteristics 
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which must be met before identifying a substance as interferon. 
These may include its source and inducing agent, its mechanism of action 
and its physico-chemical properties. In general, interferon is the 
name given to a group of anti-viral proteins produced by vertebrate 
cells in response to a number of inducing agents, including many viruses* 
It is distinct from virus material and confers resistance against 
77 
multiplication of viruses in homologous cells® As will be elucidated 
later, there have been a number of species of interferons released by 
various inducing agents and these differ somewhat in their properties. 
It has been suggested, therefore, that interference be looked upon as 
a cellular function, rather than as an isolated biochemical phenomenon® 
The remainder of this section will be devoted to a review of the present 
knowledge on the identity of interferon. 
Assay Techniques? 
To date there is no biochemical or immunologic assay for interferon® 
However, there have been a number of different interferon bio-assays 
developed. The type most widely used measures the degree of inhibition 
of virus production by cells treated with the interferon preparation 
before infection® In general, this can be measured bys(l) a decrease 
in the yield of virus from the treated cells? or (2) the decreased 
susceptibility of the infected cells to a virus lesion (e.g., a plaque 
or cytopathogenic effect). Originally, Isaacs and Lindenmarm measured 
the effect of interferon by reduction of influenza virus hemagglutinin 
titer®®^ This type of assay has largely been replaced by the more 
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sensitive plaque reduction assay in which the concentration of 
interferon that will reduce the plaque count by 50% in a tissue 
culture monolayer is measured# *' In this system a linear 
relationship exists between the percentage of plaque reduction and the 
log of the interferon concentration; therefore, it is legitimate to 
determine the end point of the assay by interpolation. Although 
this technique is not as sensitive as some, it has been used widely 
137 
because of its relative simplicity and reproducibility# Another 
h 63 
assay technique used by nitchcock is an adaptation of the Oxford 
cup technique. Its principle is that the size of a zone of protection 
afforded by interferon allowed to diffuse through agar over a sheet 
of virus-infected cells is directly proportional to the concentration 
of interferon# This technique is not widely used# 
135 
A fourth technique described by Sellers and Fitzpatrick is 
based upon the degree to which cell cultures are protected against 
cytopathogenic effect as evaluated microscopicp11y# All these 
techniques are well reviewed in ’’Techniques in Experimental Virology" 
(R.J.C. Harris, ed.)*27 
Interferon-Producing Systems* 
Soon after interferon production was described in chick cells 
infected with inactivated influenza virus, many other inducer-cell 
systems were shown to produce interferon. Ho listed almost 35 dif- 
77 
ferent systems in 1962; their range is extremely wide and has been 
constantly expanding. Most of these systems employ in vitro cell 
62 6' 
cultures; however, many in vivo models have also been described#'”'*"’ 
•*r 
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Viruses as inducers? Viruses demonstrated to induce production 
of interferon include both RE and DM viruses, a wide range of sizes 
and both cytolytic and tumor viruses. One may justifiably conclude, 
then, that the production of interferon is a rather general response 
of cells to virus infection. 
The viruses used as interferon inducers include members of the 
myxovirus, arbovirus, * polyoma, measles, 
enterovirus,'"* vesicular stomatitis/^ foot-and-mouth disease,'"' and 
47 
vaccinia virus groups. An equally impressive number of viruses have 
been shown to be inhibited by interferon and it seems quite likely that 
i 50 
no virus will be found to be completely unaffected."" (An exception 
may be the adenoviruses.'0 ) Two essential properties of virus-induced 
interferons are worth noting? (1) interferons induced by different 
viruses in a single cell system seem to be identical as far as can be 
determined; and (2) interferons induced by different viruses in a single 
cell system show no evidence of virus specificity, i.e., they are not 
150 
most active when tested against the homologous virus. 
Much has been written about the relative effectiveness of the 
various inducers of interferon. In addition to cell type and environ¬ 
mental factors, titers of interferon are influenced by the inf activity, 
dose, strain and virulence of the inducing virus* The difference in the 
relative ability of inactivated and virulent viruses to induce interferon 
is not understood. The original studies showed that UV-i motivated 
influenza virus is a better stimulator of interferon production than 
heat-inactivated or fully infectious virus* Although there is a lack 
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of entirely adequate quantitative data, there is suggestive evidence 
that infectious avirulent viruses stimulate cells to produce more 
150 
interferon than do virulent strains® Ho and gliders, in 1959, 
showed that the attenuated strain of poliovirus is a good interferon 
inducer® Vaccine strains of Newcastle Disease virus are relatively 
poor interferon inducers in chick embryo cells, although they are 
more efficient than the virulent variants® 
132 
Enders states that 
attenuated measles virus is a better interferon inducer than the 
36 
virulent strains# 
In distinct contrast to the myxoviruses, inactivated arboviruses 
and enteroviruses are notoriously poor inducers? whereas, under the 
69,146 
same conditions the identical infectious viruses elicit a good response® 
68 
Ho and Breinig reported that heat-inactivated Sindbis virus induced no 
interferon production tout “sensitized** cells released greater amounts of 
interferon when challenged with infectious virus. One explanation 
offered is that inactivated virus initiates the production of an income 
plete interferon, the synthesis and release of which may be affected by 
77 
the addition of active virus* 
It would thus seem that the capacity to induce interferon production 
is, at least in part, a property of the virus® This is supported by the 
143 
studies of Thiry who showed that one characteristic of chemically in¬ 
duced mutant strains of NDV is the capacity to induce higher yields of 
interferon per infectious particle® 
In addition to the differences in the amount of interferon which 
viruses can induce, they also differ in their sensitivity to the antiviral 
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action of interferon# (it is not known if these two properties, 
which may help to determine virus virulence, are in any way related#) 
As an example, Ruiz-Goxnez and Isaacs showed that NDV plaque re¬ 
duction required almost 30 times more interferon than an equivalent 
inhibition of 0’nyong-nyong virus# Also, Herpes simplex virus is 
much more resistant to the action of interferon than vaccinia or 
80 
cow pox viruses grown on chick chorion# Viruses which in general 
are relatively resistant to interferon action include fowl plague, 
NDV, Herpes simplex, pseudorabies and adenoviruses# (It is inter¬ 
esting to note that some members of this resistant group, especially 
Herpes and adenoviruses have been associated with long-term chronic 
infections in man#) Vaccinia, many arboviruses and rhinoviruses 
14 139 
seem to be relatively more sensitive#" * 
Non-viral inducers of interferons A variety of non-viral materials 
have been reported to be effective inducers of interferon in both in 
vivo and in vitro systems# These include heterologous animal nucleic 
78 1 72 161 88 
acids, 0,101 rickettsiae, bacteria, yeasts, statolon ( a poly- 
95 
saccharide derived from Penicillium stolonif erium), helienine (an 
133 
antibiotic-like material from Penicillium funiculosum),~ ~ cyclo- 
X 0 2 13 irp 
hexamide. Mycoplasma,10 phytohemagglutinin,J OD and, of course, 
endotoxins #^8 It has been theorized that many materials like statolon 
and helienine may be effective as inducers because they, like nucleic 
95 
acids, are polyanionic macromolecules# 
Some of these systems are certainly radically different from the 
classic virus-cell system and are in general a testament to interferon 
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production being a more general host response to insult® Isaacs 
drew the analogy that antibody production is a response to a 
foreign protein, whereas interferon production may be a response 
81 
to foreign nucleic acids at the cellular level® 
Cells involved in interferon production: In vitro, cells from 
a wide variety of animal species have been shown to produce interferon; 
these include chickens, ducks, mice, rats, guinea pigs, hamsters, rabbits, 
ferrets, dogs, sheep, pigs, cows, monkeys and man® There have been 
essentially no differences noted to date in fibroblastic, leukocytic 
and epitheloid lines with regard to interferon production or suscept* 
ibility® In vivo production has not been so extensively studied and 
there is no indication that any specific organ acts as a site for 
interferon production® 
It is generally felt that primary and secondary cell cultures are 
superior to continuous replicating cell lines for use in interferon 
assay systems®^® The tumor cell lines have been thought to be 
rather ineffectual producers of interferon, 1 but this may be due to 
the fact that many of these lines are relatively insensitive even to 
the interferon produced in the same cells. Ho and Enders noted 
that interferon produced in HeLa cell cultures infected with attenuated 
Type 2 poliovirus worked well in primary human amnion or human kidney 
cell cultures but not in infected HeLa cells® Similar findings were 
2 p 
reported by Chang in KB cells and for a human amnion cell line by 
MayerHowever, that the cell susceptibility may be only relative 
in these continuous lines was pointed out by Centell in showing that 
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HeLa cells did show some sensitivity to the action of homologous 
interferon, although less than that of primary human thyroid cells. 
Q C 
These observations led Isaacs et« al. to speculate that this be¬ 
havior might reflect general differences in metabolism between tumor 
and normal cells a 
Effect of interferon on cells: The effect of interferon on 
tissue culture cells has been actively investigated in attempt to 
elucidate the mechanism of action: 
(1) Morphological changes: With most tissue culture systems 
there has not been observed any significant morphologic change in 
interfcron-treated cells® Wagner and Levy^^ found that Eastern 
equine encephalitis virus-infected chick embryo fibroblasts treated 
with interferon had normal architecture and nucleic acid distribution® 
Pretreated cells were seen to undergo apparently normal cell divisions® 
The only morphologic changes described are in cultures of human amnion 
cells®^ Between 48 and 72 hours after treatment with interferon the 
polygonal cells became fibroblastic in shape® The cells readily re¬ 
verted to the original epithelioid type after the interferon-containing 
medium was removed® The same stimulus produced no change in primary 
human kidney cells or in continuous cell lines derived from human amnion 
cells * 
(2) Growth rate changes: Baron and Isaacs11" found that cultures of 
primary human thyroid cells subject to one hundred 50^ inhibitory doses 
of interferon resisted multiplication of vaccinia virus and continued to 
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grow and divide normally. They formed confluent monolayers at about 
122 
the same time as untreated cultures. Paucker _et. a_l., however, 
reported that treated L cells in suspension did show some growth re- 
tardation when exposed to very high titers of interferon. The signif- 
icance of the contradictory information is not apparent. 
(3) Biochemical effects: The work of Levy et. lends 
weight to the data that suggest that interferon has little effect on 
uninfected cells. They found no alteration in the incorporation of 
labeled precursors into cellular proteins, phospholipid, nucleotides 
or nucleic acids® 
Properties of Interferon 
Biological Properties:' 
1 44 
Species specificity-Tyrrell in 1959 first observed that calf 
and chick interferons were relatively species specific in that they 
were much more active in cell cultures of the homologous species. 
Later the specificity was described between chick and rabbit cells® 1 
and even for duck and chick cells. Merigan, using a highly 
purified preparation, has demonstrated that interferon produced in 
mouse tissue does not inhibit the replication of interferon-sensitive 
viruses in chick embryo cells and, conversely, that chick interferon is 
not active in mouse cultures® However, a number of workers have stated 
1 
that this specificity may not be quite so absolute® Sutton and Tyrrell 
reported on their work showing that monkey interferon was active in 
human and calf tissue, although calf interferon failed to manifest any 
activity in monkey kidney cells. Curiously enough. Sellers and 
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Fitzpa trick found just the opposite one-way relationship between 
calf and monkey interferons a135 Some more recent studies have 
demonstrated that mouse interferon exhibits about of its anti¬ 
viral activity on phylogenetically related rat embryo and hamster embryo 
cells but none on distantly related monkey testis or chick embryo 
cells.22 The data of Paucker121 seem to have contributed considerably 
in resolving the conflict. He reported that interferon activity in 
heterologous cells was reduced to about 3% of that in homologous 
systems and that this same fraction of interferon-like activity was 
not neutralized by anti-interferon antibody. Of course, this raises 
the question of the variability of specificity of interferons with 
the degree of purification of the preparation. His data suggest that 
this anti-viral activity in heterologous species may be attributable 
to viral inhibitors other than interferon* When the most purified 
interferons available at this time are used, a strong species spec- 
103 
ificity has been demonstrated. 
Antigenicity-Interferon is quite distinct as an antigen from the 
85 
virus that induces its production. Several groups of investigators 
have found interferon to be a rather poor antigen, however. When 
inoculated into rabbits or chickens either alone or with oil adjuvants 
or after alum precipitation, chick interferon did not induce the pro- 
1 I c 
duction of interferon-neutralizing antibody." Nagano and Kojima 
found that a series of injections of rabbit interferon into hens, 
guinea pigs and two groups of rabbits produced no neutralizing antibody? 
however, a third group of rabbits developed antibodies as measured in 
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rabbit skin. They later confirmed the positive observation and also 
119 
found neutralizing: substances in the serum of immunized, fowl, 
1 23 
Furthermore, Paucker and Cantell have found that after prolonged 
immunization of guinea pigs with mouse interferon a low titer of 
antibody was produced® It could be demonstrated only by using very 
dilute preparations of interferon® 
Glasgow does not find it surprising that interferon is a poor 
antigen and likens it to the polypeptide insulin. Insulins produced 
in different species vary by only a few ami.no acids and as a result 
are poor antigens when injected into heterologous species. Interferons* 
too, may vary only slightly in their structure and fail t© be recog¬ 
nized as foreign proteins by a host. 
Physico-chemical properties? 
O K 
Interferon is a non-dialyzable and non-sedimentable protein. 
Purified preparations have been found to contain no nucleic acid and 
148 
only a trace of carbohydrate. The protein, glycoprotein or poly¬ 
peptide nature of interferon is inferred primarily from the fact that 
its antiviral activity is greatly reduced or abolished by treatment 
with proteolytic enzymes such as trypsin, pepsin or chymotrypsin.^9®8»148 
On the other hand, it is not affected by treatment with ribonuclease, 
desoxyribonuclease or neuraminidase. Its ultraviolet adsorption 
spectrum is characteristic of a protein, i,e», maximum absorption at 
about 280mp* 
It is stable over a wide range of pH (from pH 2-10) j this 
property has been used to great advantage in eliminating infectious 
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virus particles from interferon preparations® The protein has been 
characterized as slightly basic with an isoelectric point at about 
pH 8®Q#^^ It is precipitated in the 60% saturated ammonium sulfate 
fraction^"0® and by acetone or ethanol® ®9^ ^ Glasgow and Habel^ 
reported that their mouse embryo interferon was inactivated by ether 
but Chany^® observed no effect when an interferon preparation derived 
from KB cells infected with parainfluenza virus was ether-treated. 
Generally the interferons have been found to be thermostable; 
some of the conflicting reports, however, may be due to pH differences 
and the stabilizing effects of other proteins in crude suspensions® 
It is stable on storage at -2°C, *XQ°C and -7G°C; and most workers 
have found only partial loss of activity at 56°C for 30 minutes*®® 
Antiviral activity is lost when preparations are heated at 76°C for 
1 hour. Although species differences in heat stability do exist, 
Chany found that his preparations of human interferon were entirely 
0 
inactivated after heating at 56 C for 30 minutes® Merigan showed 
that the heat inactivation curve of his highly purified mouse inter¬ 
feron was significantly different from similar preparations of chick 
cell interferon.^-^ 
The molecular weight of interferon has been a much-investigated 
Q £? 
topic® In 1963, Lamp son et® al * studied a highly purified prepar¬ 
ation of chick interferon and estimated, by means of high-speed 
centrifugation, that it had a molecular weight of 20,000-34,000# 
Rotem and Charlwood carried out studies of the molecular weight 
of chicken, mouse and monkey interferons by means of sedimentation in 
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sucrose density gradients along with radioactive markers of known 
molecular weight* They found each to have a molecular weight close 
to that of lysozyme with limits of 13,000-25,000* 
With the discovery of non-viral inducers of interferon, it was 
found that some of the materials meeting the standard criteria had a 
Q7 113 114 160 
wide range of molecular weights from 20,000 to 100,000*"' 9 " ' 9 ' 
At first it was thought that viruses induced the 30,000 MW interferon 
and that non-viral inducers, such as endotoxin, led to the release of 
a high molecular weight preformed interferon* However, statolon in¬ 
duces the synthesis of a 30,000 MW interferon in tissue culture,* 
and the release of a heavy species molecule into the circulation of 
animals.1" Additional findings are that the spleens of mice treated 
with statolon contain a 30,000 MW interferon and phytohemagglutinin 
1 % 
induces the formation in white blood cells of an 18,000 MW variety* 
Youngner, Hallum and Stinebring prepared the following list of 
interferon molecular weights obtained by intravenous injection of the 
various inducing agents into mice: 
Stimulus Molecular Weight by Sephadex 
G-100 gel Filtration 
Viruses t 
NDV 25,000 
Bacteria & products: 
Brucella abortus 77,000 
54,000 







♦Only light interferons have been detected in tissue culture so far., 
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It would seem., then, that a wide range of molecular sizes can be 
recovered from animals in response to various stimuli* It is not 
known whether the interferons of different molecular weights may be 
related to each other in the sense of polymers of some subunit or by 
having an active moiety attached to different protein carriers* 
It has been observed that endotoxin-induced release of high 
molecular weight interferon into the serum is not inhibited in mice 
treated with cyclohexamide to inhibit protein synthesis* The 
same results have been obtained in rabbits treated, with inhibitors of 
RM and protein synthesis? whereas, it is inhibited when virus is 
used as the inducing agent* It would seem reasonable to conclude, 
therefore, that endotoxin-induced interferon is probably not produced 
in the same way as virus-induced interferon, i.e®, that endotoxin- 
interferon does not require the synthesis of a new messenger RM or 
protein* These results have been interpreted as indicating that the 
interferon released in animals upon treatment with endotoxin is not 
newly-formed, but rather preformed in some cells, perhaps the reticulo¬ 
endothelial system* 
Mechanism of Actions 
A number of observations about the action of interferon were made 
quite soon after its discovery*^’9 J Ho and Enders,"^ Isaacs and 
Burke,Vilcek,^® and Wagner,-^9 all demonstrated quite conclusively 
that it did not act directly on the virus* Grossberg and Holland01" 
failed to detect any evidence of a block in release of newly synthesized 
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particles in poliovirus-infected cells treated with interferon. 
These data, along with evidence from Isaacs” work26*'80 that there 
was no accumulation of synthesized but unassembled viral components, 
strongly implied that the assembly and release phases of virus multi® 
plication were unaffected. Moreover, it has been demonstrated that 
interferon forms a stable complex with cells which cannot be dis- 
sociated by washing or even disrupting the cells. This means 
that interferon must be fixed to and perhaps even metabolized by the 
cell as a prerequisite to its antiviral action. Therefore, attention 
was focused on the more challenging processes involved in the intra¬ 
cellular synthesis of viral protein and nucleic acid. 
One of the first suggestions concerning the mode of action was 
that interferon-treated cell cultures showed increased glycolysis, 
increased lactic acid production and increased oxygen consumption. 
These observations are similar to those made of cell cultures exposed 
to dinitrophenol which inhibits or uncouples oxidative phosphorylation. 
These presumed effects were found to be due to impurities in the crude 
preparations of interferon, as there was no evidence for this when the 
experiments were done with purified interferon.1 Other evidence against 
1 6^ 
the hypothesis was offered by Zemla and Schramek, who were able to 
show that interferon inhibits the replication of western equine en¬ 
cephalitis virus under anaerobic conditions. Since oxidative phosphor¬ 
ylation does not occur without oxygen, it is unlikely that uncoupling 
could be the mechanism. 

More evidence bep-an to accumulate about the precise site of 
interferon action, DeSomer34 demonstrated that interferon inhib- 
54 
ited the synthesis of viral RM and also Grossberg and Holland, 
Ho,'®® and Mayer et.al.^® proved that this inhibition was exerted 
on infectious viral RM as well as on whole virus. These data con¬ 
firmed earlier impressions that interferon acts intr&celluiarly and 
more specifically on the synthesis of -viral nucleic acids and protein. 
An interesting observation made by Houo is that over a narrow 
dosage range the inhibitor of virus plaque formation conforms to 
first-order kinetics. This has been interpreted as implying that 
perhaps as little as one molecule of interferon is sufficient to 
render one cell resistant to virus infection. 
A series of experiments described by Taylor in 1964^4^ 
added much to the attempt to further define the mode of action. 
She took advantage of the fact that the antibiotic actinomycin D 
inhibits DNA-dependent RM synthesis without affecting viral RM 
synthesis in cells infected with Semliki Forest Disease virus. 
In the absence of interferon, actinomycin-treated and infected 
cells incorporated tritium-labeled adenosine into viral RM. and 
the virus multiplied normally. When cells were first treated with 
partially purified interferon for 5 hours and then treated with 
actinomycin D overnight and infected with virus, the synthesis of 
viral RM and the yield of progeny were markedly reduced. However, 
if the cells were treated with actinomycin before they were exposed 
to interferon, viral RM synthesis and viral replication were not 
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inhibited by interferon# These data have been construed as evidence 
that interferon acts by inducing cellular synthesis of a new messenger 
M which, in turn, presumably codes for the synthesis of a new cell® 
ular protein* It would seem that this interferon-induced protein 
appears to be the active component in this inhibition of viral RN& 
synthesis* 
These results have been confirmed by Lockhart-*-06 who als© 
demonstrated that actinomycin can reverse the antiviral action of 
interferon for a period of 2 to 3 hours after exposure* Additional 
weight has been lent to these theories by reports that selective in¬ 
hibitors of protein synthesis, p-fluorophenylalanine4'''’ and puromycin1,01 
also block interferon action* Thus far, no one has isolated the 
interferon-induced protein that inhibits viral RNA synthesis but 
the evidence for its existence seems conclusive* 
Very recently, Marcus and Salb-*-u^ have published evidence further 
elucidating the precise site of interferon action* The authors used 
a cell-free protein synthesizing system, with Sindbis virus RNA as 
messenger and ribosomes from normal and interferon-treated chick 
embryo cells. Using polyribosome, breakdown (as evidenced by loss 
or ribosomai RNA absorbancy and labeled viral RNA from the 250 $ 
region) as evidence of messenger RNA readout and protein synthesis in 
normal and interferon-treated cells, they showed that interferon inhibits 
virus messenger RNA translation, while messenger from the cell genome 
is translated normally* They therefore postulate that the inhibition 
8 




Thus it can be seen that although much about interferon 
remains to be learned, a tremendous amount of information has 





Fever is one of the most common signs of illness , but until quite 
recently little has been understood about its pathogenesis* In the 
mid-nineteenth century pyrogenic agents were found in pus and nec- 
1 Q 
rotizing tissues. Later, Hort and Penfold, while studying 
"injection fevers" found that the pyrogenic agents were in fact 
bacterial cell contaminants* The most potent of these pyrogens 
were shown to be soluble materials associated with gram negative 
bacteriaand for some time it was taken for granted that most 
clinical fevers were directly related to these pyrogens* The 
concept of pyrogens of endogenous origin was reintroduced by Menkin 
who found a "pyrexin" in inflammatory exudatesHowever, 
his material was later shown to have characteristics identical with 
bacterial endotoxin and probably was due to gram negative bacterial 
endotoxin contamination* 
The existence of a pyrogen truly endogenous to an animal was 
first demonstrated by Beeson^0 in polymorphonuclear leukocytes ob¬ 
tained from sterile saline-induced peritoneal exudates* The cells 
were lysed by shaking with glass beads and the supernatants were 
shown to be pyrogenic when injected intravenously into rabbits* 
This pyrogen was clearly different from endotoxin in its heat 
lability, rapidity of action and the absence of tolerance to re¬ 
peated injection. However, in screening other rabbit tissues. 
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Bennett and Beeson^ were unable to find evidence of pyrogen 
except in those containing large numbers of leukocytes. 
Much of the experimental fever work has been done with gram 
negative bacterial endotoxins, lipopolysaccharides of about one 
QQ 
million molecular weight. It has been quite well demonstrated 
that the pyrogenic effects of endotoxins are mediated in large 
part through the release of an endogenous pyrogen, presumably from 
17 
circulating granulocytes. The release of this pyrogenic substance 
has also been demonstrated in vitro. 
Endotoxins when given intravenously characteristically induce 
158 IgQ 
a fever with a latent period of 20-30 minutes. * When suf¬ 
ficient endotoxin is given, the response is a biphasie fever with 
peaks at one and three hours.0® The response of circulating leuko¬ 
cytes varies with the dose of endotoxins small doses evoke no change 
or only a progressive leukocytosis without an initial leukopenia; 
larger doses, however, cause an initial leukopenia during the 
Q 
latency period, followed by a leukocytosis. 
Several other experimental fever systems have been shown to 
involve the release of an endogenous pyrogen: 
(l) Gram positive bacteria do not possess the Xipopolysaceharide 
endotoxins that are found in virtually all gram negative organisms 
It was thought from very early experiments that gram positive bacteria 
were not immediately pyrogenic when given intravenously. A fever 
appeared only after several hours delay when an infection was estab- 
74 
lished® This was shown not to be the case, however, by Atkins and 
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Freedman in 1963* Large numbers of autoclaved gram positive 
organisms given intravenously caused biphasic fevers after a 
latent period of 45-60 minutes* This delay period is signif¬ 
icantly longer than that for endotoxins given by the same route* 
Streptococci have also been shown to contain several non-infectious 
pyrogenic material s*^9^^ 
It should be pointed out that intravenous injection of a 
number of relatively inert materials also have produced fever 
with many of the characteristics of gram positive bacteria* 
These include dextran, methyl cellulose, calcium phosphate, 
0 
sulfur, kaolin, quartz, thorium dioxide, iron oxide and gold*' 
(2) Viruses have been shown to produce fever in rabbits 
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when injected intravenously* '9 The fever associated with 
virus is somewhat different from endotoxin and gram positive 
bacteria-induced fever* It has a latent period of between 
1 R] 
one and two hours rather than 20-30 minutes9 9 1 and is as- 
CO 
sociated with a lymphopenia rather than a granulocytic response. 
The pyrogenic property of the myxoviruses is abolished by incu¬ 
bation with specific immune seruni,^^^ whereas homologous antibody 
does not affect endotoxin5 s ability to produce a fever. It seems 
probable, then, that the initial mechanism of fever production by 
virus differs in some basic way from endotoxin fever. 
Several investigators have shown that the mediator of virus- 




and endogenous pyrogens associated with other systems® 
Recently Atkins et® al®ij have demonstrated that a myxovirus 
can cause release of an endogenous pyrogen when mixed in 
vitro 'with whole rabbit blood® Rabbit alveolar macrophages 
have also been shown to release pyrogen in response to whole 
3 
virus and to a polysaccharide extract of the virus® Although 
a relatively few viruses have been tested for pyrogenicity» 
Coxsackie virus has been the only one beside the myxovirus group 
to induc e f ev er «9^ ^ 
(3) Another experimental fever system shown to involve the 
release of endogenous pyrogen encompasses several immunologic 
mechanisms® Farr et® *>39,40 used repeated intravenous 
injections of bovine serum albumin to sensitize rabbits to 
respond with a fever to subsequent challenge with the protein® 
The febrile response 'was biphasic and accompanied by leukopenia 
but differed from endotoxin fever in its longer latency period® 
Circulating antibodies were shown to be involved in the release 
of the endogenous pyrogen by passive transfer experiments. Lymph¬ 
ocytes transferred from sensitized to normal animals did not mediate 
the response®9 ^ It is probably a fair conclusion that an antigen- 
antibody reaction causes host cells to release endogenous pyrogen 
into the blood stream® 
Delayed hypersensitivity has also been shown, to be a mechanism 
that releases endogenous pyrogen® Rabbits which have been infected 
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■with BCG vaccine have significant febrile reactions to intra- 
cry 
venous injections of old tuberculin*1"'' The reaction involves 
an early granulocytopenia followed by a prolonged lymphopenia 
which is a characteristic reaction of delayed hypersensitivity.''' 
This type of fever is distinguished from endotoxin fever by its 
latency of nearly one hour. Atkins and Heijn^ further demon¬ 
strated that tuberculin releases endogenous pyrogen in vitro 
from blood leukocytes of sensitized rabbits, but not from lymph 
node and spleen cells. Since normal blood cells, incubated in 
plasma of sensitized donors, were also activated, it was post¬ 
ulated that circulating antibodies sensitize cells (presumably 
granulocytes) to release endogenous pyrogen on contact with 
tuberculin. 
Fevers have also been shown to be produced with products of 
g 
other microorganisms® Culture filtrates of Staphylococcus aureus 
21 
and of several of the pathogenic fungi “ have been shown to induce 
febrile resnonses in nornal rabbits, Atkins postulates that these 
responses are due to sensitization by undetec ted previous infections 
of the Hnormal*' animals by homologous or cross-reacting organisms. 
Bod el and Atkins showed that this phenomenon can be passively 
transferred with lymphocytes but not serum, and therefore presumably 
is due to delayed hypersensitivity. 
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End ogenous Pyrogens 
As mentioned previously polymorphonuclear leukocytes in 
sterile saline-induced peritoneal exudates were first shown 
by Beeson^® to release endogenous pyrogen® Subsequent work by 
several investigators 3ms shown that normal blood leukocytes, 
both of rabbits®® and man, contain essentially no pre-formed 
pyrogen® Leukocytes release pyrogen only in response to a number 
of stimuli as previously described. It had been thought for some 
time that only granulocytic leukocytes were involved in the release 
of endogenous pyrogen. However, recently Atkins has demonstrated 
that mononuclear macrophages which line the respiratory tree of 
rabbits can be stimulated to release pyrogen by several agents. 
Endogenous pyrogen is characterized by the rapidity of onset 
of fever production when it is injected intravenously. Unlike 
other pyrogens that produce fever only after a variable period of 
latency, endogenous pyrogen produces an immediate, quickly rising 
fever with a 5-10 minute lag. Another characteristic is the failure 
of an animal to develop significant tolerance to repeated injections 
of endogenous pyrogen. This is in distinct contrast to most exogenous 
ft ft 
pyrogens* Atkins and Huang, however, described a very interesting 
phenomenon that may be related to tolerance® Large doses of leukocytic 
pyrogen produce an immediate, biphasic fever with peaks at one and 
three hours. Repeated injections of such large doses leads to the 
eventual disappearance of the second fever peak but never the first® 
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Atkins believes that this may be explained as a direct action 
on the thermoregulatory centers causing the first peak, while 
the pyrogen causes the release of the recipient animal’s own 
endogenous pyrogen to cause the second fever peak. The mechanism 
of partial tolerance seems to involve only the release of pyrogen 
1 1 
from the recipient’s cells. 
Species specificity; 
The question of species specificity has been raised with 
regard to endogenous pyrogens, although little quantative data 
124 
is available, Petersdorf and Bennett in 1957 ' described their 
experiments with sterile peritoneal exudates from dogs and rabbits. 
The exudates contained pyrogens that were identical to previously 
described leukocytic pyrogens in that they produced immediate fevers 
in homologous animals. Of note in their early experiments is that, 
although the exudate pyrogen was quite active in the homologous 
animal, it was entirely inactive in a heterologous system, i,e,9 
rabbit pyrogen was not active in dogs, nor was canine pyrogen active 
in rabbits. Their conclusion was that species specificity might be 
an important character of endogenous pyrogens* Later experiments by 
the same investigators show that canine serum endogenous pyrogen does 
cause prompt monophasic fevers in rabbits®’’'^However, since they could 
not demonstrate a dose-related response, they concluded again that 
the pyrogens are species specific. It would seem that this is not 
necessarily the most logical conclusion from their experimental 




More recently Bod el and Atkins have shown that human blood 
leukocytes, after incubation with endotoxin derived from Proteus 
vulgaris or with heat«>killed Staphylococcus albus cells, release 
a potent pyrogen that produces fever in rabbits and is distinct 
from contaminating bacterial pyrogen* 
Thus, the question, of species specificity is not resolved at 
this time and awaits the outcome of more extensive experiments* 
Naturally occuring pyrogens: 
Soon after the discovery of granulocytic pyrogen, Bennett and 
1 7 
Beeson reported on their efforts to find pyrogen occuring in 
rabbit tissues other than leukocytes* In short, they were unable 
to find evidence of any pyrogenic material in extracts of normal 
or inf arc ted kidney, spleen, heart or lung* Likewise, no febrile 
response could be elicited from extracts of erythrocytes, lymphocytes 
or macrophages from peritoneal exudates* Extracts of acute inflam® 
matory cutaneous Shwartsman and Arthus lesions produced fever when 
injected intravenously* The authors postulated that the large number 
of polymorphonuclear leukocytes in these reactions could explain the 
fevers observed* 
Later, Snell and Atkins^® attempted again to demonstrate an 
endogenous pyrogen in normal rabbit tissues, largely because there 
are clinical and experimental fevers in which granulocytes do not 
seem to be implicated* Indeed, by using larger quantities of tissue 
extracts than had been used before, they found that skeletal and 
abdominal muscle, diaphragm, liver, kidney, heart, lung and spleen 
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all yielded detectable pyrogen which in all but one case (kidney) 
produced fevers much like granulocytic pyrogen. These responses 
were clearly shown not to be attributable to endotoxin contain" 
inants and most unlikely due to sequestered granulocytes in the 
homogenates. 
Physico-chemical properties? 
Because exact quantitation is difficult by the bioassay for 
endogenous pyrogen, purification and biochemical characterization 
1 29 
has been quite difficult. Rafter et. al. in 1960 described 
some characteristics of the pyrogenic component of sterile rabbit 
peritoneal exudates. It was shown to be a non-dialyzable protein 
which is precipitated by perchloric acid and extractable with phenol? 
it is soluble in 50% methanol and 33% saturated, ammonium sulfate. 
At that time they had achieved approximately 50-fold purification 
by a combination of chemical and chromatographic techniques. This 
partially purified material contained less than 1% carbohydrate^ 
was resistant to periodate oxidation and was unaffected by butanol 
extraction. They also showed that this material contained at least 
two components when tested by immunophoresis in Ouohterlony gel plates. 
In some later studies, Hadley _et. al^, described their pyrogen 
obtained from serum of rabbits treated with intravenous Newcastle 
Disease virus. They achieved a 25-fold purification of the serum pyrogen 
by successive acid and ethanol precipitations. It was found to be 
non-dialyzable and at least partially protein in nature in that it 
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was destroyed by pepsin and trypsin* It was extractable by phenol 
but not by butanol and partially inactivated by periodate oxidation* 
As can be seen, this virus-induced pyrogen has some characteristics 
in common with Rafter9 s granulocytic pyrogen, but because of the 
relatively crude preparations, no more exacting comparison can be 
drawn® 
1 2ft 
Recently, Rafter et« al® have reported on their further 
modified technique of purification and some further characterization 
of the leukocytic pyrogen, it appears to be a lipo-protein complex 
having a molecular weight between 109000 and 20,000 by sucrose 
gradient centrifugation* They offer several lines of evidence that 
it contains an essential lipid components (1) inactivation by cuprous 
ions? (2) lability in solutions of pH 8*5 and aboves and (3) loss of 
pyrogenicity after extraction with acid-isooctane* Its solubility 
in 66% methanol and the enhancing action of ethanol in freeing it 
from sonicated cells are cited as evidence of the presence of exposed 
lipid groups at its surface. The authors believe that the demon¬ 
stration of an essential lipid component adds weight to the hypothesis 
that leukocytic pyrogen is derived from cellular membranes. 
Atkins has shown that protein synthesis is necessary for the 
action of endogenous pyrogen®^ However, essentially nothing else is 
known about its mechanism of action. The site of action has been 
presumed to be the brain since the response to intracarotid injection 
is greater than to intravenous injection©94 
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MATERIALS AND METHODS 
1 nterf eron 
Virus Strains? A stock of a rabbit kidney cell-adapted 
Sindbis virus (Egypt AR-339) was obtained by inoculation of 
0*lec of a 10"1 dilution of the original stock onto 5-day 
monolayer cultures of chick embryo fibroblasts. The tissue 
culture medium was harvested after 48 hours and made up to a 
10# solution of bovine serum albumin. The stock originally 
titered to 10® TCID^q per ml. on tube cultures of primary 
rabbit kidney cells. The virus was stored in 1 ml. aliquots 
at -70°C until used. 
Vesicular stomatitis virus (Indiana) was prepared by in- 
oculating 0.1 ml, of a 10 dilution of the original virus 
suspension intracerebrally into suckling mice. The mice brains 
were harvested in 48 hours and homogenized in a solution of 10# 
bovine serum albumin. The virus was distributed into 1 ml. 
aliquots and stored at -70°C until used. The original titer of 
the rims was 10® TCIDgQ per ml. on tube cultures of primary 
rabbit kidney cells® 
Tissue Culture Media? Two types of tissue culture media 
were used* 
H Hanks’ Growth Medium’*- Hanks’ salt solution base with 0.5# 
lactaibumin hydrolysate, 5# fetal calf serum, phenol red indi¬ 
cator and approximately 200 units of penicillin and 200 p g of 
streptomycin per ml. Final pH 7.6-7,8. 
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wfferle’s Maintenance Medium*- Earle’s salt solution base with 0»5% 
lactalbuiriin hydrolysate, 5% calf serum, phenol red indicator and 
approximately 200 units of penicillin and 200^ g of streptomycin 
per ml. Final pH 7.6-7.8* 
Overlay medium- 0.5$ lactalbumin hydrolysate in Hanks' balanced 
salt solution, b% calf serum, sodium bicarbonate, 1,5% agar (Special 
Agar-Noble, Difco Labs.), antibiotics, and neutral red (1*5$ of a 
1i1000 solution per 100 ml.) 
Primary rabbit kidney tissue cultures: Two to 3 kg. white 
New Zealand rabbits were killed by air embolism and the kidneys 
were removed asceptically» The capsules were removed and the kidneys 
were washed in phosphate-buffered saline® The cortices of the 
kidneys were cut off and minced into small fragments. The tissue 
was transferred to a 125 ml, trypsinizing flask and 50 ml, of pre- 
warmed 0»25%o trypsin (Flow Laboratories) in Earle's balanced, salt 
solution was added to the flask. The material was stirred at a 
moderate speed by a magnetic stirrer for approximately 5 minutes# 
The supernatant cell suspension was decanted into an Erlenmeyer 
flask containing 50 ml. of chilled Hanks’ balanced salts solution 
and kept cold. The trypsinization was repeated until the kidney 
tissue was exhausted; this usually required about 4-5 aliquots of 
trypsin. 
The cell suspension was then centrifuged in 200 ml, centrifuge 
bottles at about 1000 RPM in an International FR2 centrifuge at 4°C, 
The supernatant solution was decanted and the packed cells were 
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resuspend ed in 50 ml. of Hanks’ growth medium. The cell suspension 
was filtered through 6 layers of sterile gauze and a cell count was 
done on the .resulting suspension. The cell concentration was ad” 
justed to 4 X 10® cells per ml. and dispensed ( 1 ml. into 16 mm 
culture tubes] 10 ml. into 3 oz. prescription bottles). 
Three days after seeding, the original medium was replaced with 
an equal volume of Hanks’ growth medium. This was done earlier if the 
medium became acid. Monolayers were usually formed in 7 to 10 days 
and were maintained until used with Earle’s maintenance medium. 
Interference Assays: Two types of interference assays were 
used, CPE«reduction in tube cultures and a plaque reduction method 
in the prescription bottles. 
(1) Tube cultures of primary rabbit kidney cells were prepared 
as outlined above. The solution to be tested for interferon activity 
was freed of inducing virus in one of two ways. The sample was heated 
for 1 hour at 56°C and then centrifuged to removed precipitated matter 
or it was dialyzed against 0.2 M KC1-HC1 buffer at pH 2.0 for 24 hours 
at 4°C. The pH was readjusted to 7.4 by re-dialyzing against Earle’s 
balanced salts solution for an additional 12 hours. These methods 
have both been demonstrated to inactivate the viruses used but not 
the interferon.®^The former was usually used because of its 
simplicity and brevity. 
Serial 2*»fold dilutions were made of the solution to be tested. 
The maintenance medium was then decanted from the tube cultures and 
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0*5 ml• of the tested material was added to each tube* The material 
was incubated at 37°C for 8 to 12 hours and then a challenging dose 
of 1000 TCIDgQ of Sindbis virus in 1 ml. was added and allowed to 
adsorb for 4 hours. Assays were run in quadruplicate. Controls 
consisted of using 1 ml. of Erie’s maintenance medium instead of 
the virus. After the virus adsorption 1.0 ml. Earle’s maintenance 
medium was added and the cultures were incubated at 37°C. They 
were checked at 12 hour intervals for the development of cytopatho- 
genic effect, and the titer of interferon was considered to be the 
highest dilution at which 50$ of the cultures showed inhibition of 
CPF as interpolated by the Reed-Mueneh method.-^0- 
Because the plaque reduction type of assay has been found to be 
a more sensitive indicator of interferon activity than the CPE re- 
duction method, it was also tested. Confluent monolayers of the rabbit 
kidney cells in 3 oz. prescription bottles were usually attained 10 
days after seeding. Here, too, 2-fold serial dilutions of the material 
to be tested were made and o»5 ml. aliquots of the solution were 
incubated at 37°C for 8 to 12 hours with the cell sheets. A challenge 
dose of 30-100 PFU of the Sindbis virus was added to each bottle and 
allowed to adsorb for 4 hours. The cultures were then overlaid with 
plaquing medium and incubated upside down in a totally dark environ¬ 
ment. The highest dilution of the test material which reduced the 
number of plaques to 50$ of the inoculum as determined by controls 
was to be considered to be the titer of interferon. The plaquing 
technique did not work, probably because the concentration of neutral 
red was toxic for the cells 
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End ogenous Pyrogen 
General; Pyrogenicity assays were done in rabbits in order 
to be able best to compare interferon and endogenous pyrogen in a 
homologous system. 
Male and female albino rabbits weighing 3-5 kg. were used 
both as donors and recipients of materials to be assayed for 
pyrogenicity.57 They were all caged individually in an air- 
conditioned room and temperatures were recorded in an adjacent 
room maintained at 65 to 70° F. 
All glassware and needles were sterilized and made pyrogen™ 
free by dry heat at 170°C for 2 hours. Commercial pyrogen-free 
Cutter physiologic saline solution was used throughout. All 
materials were given to the rabbits intravenously by the marginal 
ear veins. 
Temperature recording; Temperatures were recorded with rectal 
thermistors with a Foxboro scanning switch fever recorder. Rabbits 
were restrained in metal or wooden stalls with openings for the head 
and tail. Before use, rabbits were trained by being restrained for 
at least one 5 hour period. They were not given food or water during 
an experiment. Only rabbits whose temperature did not exceed 40.5° C 
and did not vary by more than o.3° C during the hour before injection 
were used. Temperatures were recorded every 15 minutes for the dur¬ 
ation of the experiment. Some animals that had remained afebrile or 
had rapidly regained a normal temperature were given a second dose 
if they remained stable for at least 1 hour. 
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EXPERX MENTAL AND DISCUSSION 
It must be stated at the outset that a satisfactory series 
of experiments were never completed to resolve the questions 
originally posed® However, an explanation of what was attempted 
and why the experiments were not successful will be presented in 
this section® 
The general experimental approach in assessing a possible 
relationship between viral interference and endogenous pyrogen 
was to compare these two phenomena in a single host system so 
that any conclusions drawn would be unaffected by questions of 
species specificity® For this reason, and the fact that a well** 
controlled pyrogen assay was readily available, the rabbit was 
chosen as the source of host cells* It was proposed to do recip¬ 
rocal experiments, i*e», to test material known to contain interferon 
for its pyrogenicity and to test material shown to contain endogenous 
pyrogen for its interfering properties® 
Ho describes a reliable assay using primary rabbit kidney 
tissue cultures with vesicular stomatitis and Sindbis viruses as 
inducing and assay virus, respectively® It was thought that this 
would be a suitable system to employ in investigating this problem® 
Two major experiments were attempted; 
(l) Monolayer cultures of the rabbit kidney cells in 3 oz» pre- 
/? 
scription bottles ( approximately 10° cells per bottle) were washed 
twice with 10 cc of the pyrogen-free tissue culture medium* They 
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were then infected with 0.2 ml. of a 10”1 dilution of the VSV 
stock which was allowed to adsorb for 30 minutes. Ten ml. of the 
pyrogen-free medium was added and the cultures were incubated at 
37°C for 12 hours. At that time about 50% of the cells were 
observed to have detached from the glass in both uninoculated 
control bottles and infected cultures. There was no sign of any 
specific cytopathogenic effect® The medium was decanted and the 
virus was h©at-imotivated as described earlier. It was then 
clarified by low-speed centrifugation and injected into rabbits 
to test for pyrogenicity. Both samples from uninfected controls 
and infected cultures were found to elicit no febrile response 
in the recipient rabbits. 
When this material was assayed for interferon by the tube 
dilution technique using Sindbis as a challenge virus, no inter® 
ference was demonstrable. 
(2) An attempt was made to assay material known to contain 
endogenous pyrogen for virus interfering activity. Rabbit alveolar 
macrophages were suspended in a phosphate-buffered balanced salt 
solution at pH 7.2. They were incubated overnight at 37°C with 
purified tuberculin protein. The cellular material was removed by 
centrifugation and the supernatant was demonstrated to cause an 
immediate monoph&sie fever in rabbits. 
Serial 2-fold dilutions were made of this supernatant and 
0.5 ml. aliquots were added in replicates to tube cultures of the 
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rabbit kidney cells after the medium was decanted* These were then 
incubated for 8 hours and then challenged with 1000 TCIDgg of the 
VS virus (Indiana) in 0*1 ml* The virus was allowed to adsorb for 
30 minutes after which 1.0 ml* maintenance medium was added. There 
was no interference demonstrable during the ensuing 3 day period* 
See Tabl el* 
Table I* Interferon Assay: CPE in rabbit kidney cell cultures 
challenged with 1000 TCIDqq VSV (Indiana) read on 
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8 hr 0 0 
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0 0 0 0 0 
16 hr 0 0 0 0 0 0 0 





1 2 1 
48 hr 3 3 3 
- 
3 3 3 3 
72 hr 4 4 | 3 Li 4 4 L-—-- 4 
On many attempts, the major difficulty lay in trying to establish 
a positive interferon assay* The first problem encountered was with 
the cell cultures themselves* Early in the course of experimentation 
the cells were found to grow quite slowly compared to other cell 
systems and the shortest time in which monolayer cultures were achieved 
was 10 days • At this time, the cell layer was confluent but rather 
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thin when compared to chick embryo fibroblast and rhesus monkey 
kidney cultures of the same age* Variations in types of media 
and serum concentrations during the early growth phase of the 
cultures were found to be ineffectual in achieving a more rapid 
growth or heavier monolayers® 
Another problem that was encountered early was that in order 
to assay for endogenous pyrogen, any material tested by intra- 
venous injection had to be free of any contaminating pyrogens, 
either infectious or non-infectious» Screening of a number of 
commercially available tissue culture media showed that they 
were invariably pyrogenic for rabbits# although sterile by culture* 
The fever pattern produced was quite typical of an endotoxin-like 
pyrogen and undoubtedly resulted from endotoxin contamination 
during commercial preparation since all materials used in our 
laboratories were pyrogen-free* 
In an attempt to solve this problem, an Earle’s balanced 
salts solution-base pyrogen-free tissue culture medium was pre¬ 
pared from basic ingredients that were demonstrated to be pyrogen- 
free* This involved 2 hour autoclaving of components of the salts 
solution separately ( as described by Hsiung^®) and similar treat¬ 
ment of Xactalbumin hydrolysate* Pyrogen-free rabbit serum was 
used in place of calf serum* This type of medium was never found 
to be satisfactory in that, although it was not pyrogenic, it was 
incapable of maintaining the cell sheet for the time required for 
interferon production* After about 6 hours incubation in this medium. 
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uninfected cells could be observed to be degenerating® ( An 
explanation might be that the essential polypeptide and amino 
acids in the lactalbumin hydrolysate were destroyed by the long 
period of autoclaving. ) 
A manner of eliminating the problem of pyrogenic tissue 
culture media might be to use rabbits for the pyrogen assay that 
have been made tolerant by repeated IV injections of endotoxins# 
Rabbits treated this way have been shown to be unresponsive to 
P 
endotoxins but to remain responsive to endogenous pyrogens. 
Other difficulties, loss of virus stocks and contaminations, 
occurred before this could be attempted# 
It is felt that because a positive assay for interferon was 
never achieved, no valid conclusions could be drawn from these 
two unsatisfactory experiments® They could not be repeated because 
of a very distressing gradual decline in the Sindbis virus titer, 
even though the virus was stored at -70°C in 10% bovine serum 
albumin® Bacterial and fungal contaminants of the tissue cultures 
also were perplexing problems® 
In conclusion, the problem posed is a challenging one, but 
probably soluble with some further refinement of experimental 
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